Backed by Clinical Evidence

Real world evidence from more than 4800 samples over 7 years found Delve Detect delivers 22% greater diagnostic yield than all other infectious disease tests combined.

Evidence Spotlight

Largest study on mNGS using CSF confirms its impact in diagnosing serious neurological infections

A groundbreaking study published in Nature Medicine, the largest of its kind, establishes mNGS as a crucial diagnostic tool for central nervous system (CNS) infections. Findings showed that mNGS technology significantly enhances diagnostic yield, supporting faster, targeted treatment decisions for patients.

Want to hear more about our technology?